What MedGenome does
Founded in 2013, MedGenome is a genomics and diagnostics company. The health tech company offers advanced genetic testing across oncology, cardiology, and reproductive health. The soonicorn began with clinical genomics services and gradually expanded into full-spectrum sequencing and precision diagnostics. In 2024, MedGenome acquired stakes in GenX Diagnostics and Prognosis Labs to strengthen its presence in East India and broaden its testing capabilities. With a revenue of Rs 299.27 Cr in FY24, MedGenome competes with companies including Strand Life Sciences and MapMyGenome.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about MedGenome yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.